- Home
- DCGO vs XGN Comparison
DCGO vs XGN Comparison
Compare DCGO & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCGO
- XGN
- Stock Information
- Founded
- DCGO 2015
- XGN 2002
- Country
- DCGO United States
- XGN United States
- Employees
- DCGO N/A
- XGN N/A
- Industry
- DCGO Managed Health Care
- XGN Medical Specialities
- Sector
- DCGO Health Care
- XGN Health Care
- Exchange
- DCGO Nasdaq
- XGN Nasdaq
- Market Cap
- DCGO 139.7M
- XGN 138.3M
- IPO Year
- DCGO N/A
- XGN 2019
- Fundamental
- Price
- DCGO $1.56
- XGN $9.31
- Analyst Decision
- DCGO Strong Buy
- XGN Strong Buy
- Analyst Count
- DCGO 4
- XGN 5
- Target Price
- DCGO $3.78
- XGN $12.40
- AVG Volume (30 Days)
- DCGO 321.8K
- XGN 210.4K
- Earning Date
- DCGO 11-06-2025
- XGN 11-11-2025
- Dividend Yield
- DCGO N/A
- XGN N/A
- EPS Growth
- DCGO N/A
- XGN N/A
- EPS
- DCGO N/A
- XGN N/A
- Revenue
- DCGO $435,968,564.00
- XGN $58,862,000.00
- Revenue This Year
- DCGO N/A
- XGN $22.09
- Revenue Next Year
- DCGO N/A
- XGN $13.62
- P/E Ratio
- DCGO N/A
- XGN N/A
- Revenue Growth
- DCGO N/A
- XGN 3.89
- 52 Week Low
- DCGO $1.23
- XGN $2.38
- 52 Week High
- DCGO $5.68
- XGN $10.34
- Technical
- Relative Strength Index (RSI)
- DCGO 49.80
- XGN 47.62
- Support Level
- DCGO $1.48
- XGN $9.55
- Resistance Level
- DCGO $1.61
- XGN $10.28
- Average True Range (ATR)
- DCGO 0.07
- XGN 0.39
- MACD
- DCGO -0.01
- XGN -0.11
- Stochastic Oscillator
- DCGO 41.46
- XGN 11.81
About DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.